Study Examines Risk for ONJ in Cancer Patients Who Take Bone-Modifying Agents
An investigation by researchers at the University of Michigan Comprehensive Cancer Center in Ann Arbor examined the association between osteonecrosis of the jaw (ONJ) n cancer patients and the use of bone-modifying agents to reduce the…